Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 02, 2025

Get In Touch

Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal Pharma News

Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal

  • 24 October 2025
  • 1 week ago

CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India Pharma News

CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India

  • 21 October 2025
  • 1 week ago

Rs 233 Crore in 6 Months: Mounjaro Becomes India's Second-Biggest Drug by Sales Pharma News

Rs 233 Crore in 6 Months: Mounjaro Becomes India's Second-Biggest Drug by Sales

  • 10 October 2025
  • 3 weeks ago

Tirzepatide Improved Outcomes in Patients with Both Atrial Fibrillation and COPD: Study Cardiology and CTVS

Tirzepatide Improved Outcomes in Patients with Both Atrial Fibrillation and COPD: Study

  • 04 October 2025
  • 4 weeks ago

Tirzepatide Improves Blood Sugar Control in Children With Type 2 Diabetes: SURPASS-PEDS Trial Diabetes and Endocrinology

Tirzepatide Improves Blood Sugar Control in Children With Type 2 Diabetes: SURPASS-PEDS Trial

  • 20 September 2025
  • 1 month ago

Tirzepatide and Thiazide Use in CKD Linked to Risk of Severe Hypercalcemia, Reveals Case Report Diabetes and Endocrinology

Tirzepatide and Thiazide Use in CKD Linked to Risk of Severe Hypercalcemia, Reveals Case Report

  • 16 September 2025
  • 1 month ago

Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic liver disease, reports research Gastroenterology

Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic liver disease, reports research

  • 13 September 2025
  • 1 month ago

EMA warns of sharp rise in illegal medicines sold in EU Diabetes and Endocrinology

EMA warns of sharp rise in illegal medicines sold in EU

  • 09 September 2025
  • 1 month ago

Tirzepatide Significantly Lowers Albuminuria Across All Administered Doses In Patients With Type 2 Diabetes: Study Nephrology

Tirzepatide Significantly Lowers Albuminuria Across All Administered Doses In Patients With Type 2 Diabetes: Study

  • 27 July 2025
  • 3 months ago

Recent News

SR Post VACANCIES At ESIC Model Hospital Noida, Ch...

  • 02 November, 2025

Pathologist's signature on medical reports not mus...

  • 02 November, 2025

UP Eyes Japanese Investment: 125 Pharma Giants Inv...

  • 02 November, 2025

Delhi Govt to recruit 1,593 senior resident doctor...

  • 02 November, 2025

Former Drug Inspector's Office Clerk Jailed for Ta...

  • 02 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.